SARTORIS, Silvia
 Distribuzione geografica
Continente #
EU - Europa 4.717
NA - Nord America 4.125
AS - Asia 2.750
SA - Sud America 482
AF - Africa 47
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 5
Totale 12.132
Nazione #
US - Stati Uniti d'America 4.058
RU - Federazione Russa 1.643
GB - Regno Unito 1.194
SG - Singapore 1.058
CN - Cina 978
DE - Germania 408
BR - Brasile 382
IT - Italia 326
FI - Finlandia 270
SE - Svezia 234
HK - Hong Kong 229
FR - Francia 211
IE - Irlanda 188
VN - Vietnam 187
UA - Ucraina 73
KR - Corea 67
AR - Argentina 40
NL - Olanda 37
TR - Turchia 37
ID - Indonesia 35
IN - India 33
PL - Polonia 30
CA - Canada 29
BE - Belgio 26
JP - Giappone 25
MX - Messico 22
ES - Italia 21
ZA - Sudafrica 19
BD - Bangladesh 16
EC - Ecuador 13
IQ - Iraq 13
PK - Pakistan 13
AT - Austria 12
VE - Venezuela 12
CO - Colombia 10
IR - Iran 9
PY - Paraguay 9
CL - Cile 7
IL - Israele 7
SA - Arabia Saudita 7
AU - Australia 6
CZ - Repubblica Ceca 6
LV - Lettonia 6
CH - Svizzera 5
JO - Giordania 5
LU - Lussemburgo 5
PE - Perù 5
UZ - Uzbekistan 5
EG - Egitto 4
EU - Europa 4
KG - Kirghizistan 4
LT - Lituania 4
MA - Marocco 4
PA - Panama 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
BJ - Benin 3
BO - Bolivia 3
KZ - Kazakistan 3
TG - Togo 3
AL - Albania 2
BG - Bulgaria 2
CR - Costa Rica 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
KE - Kenya 2
LB - Libano 2
MY - Malesia 2
NI - Nicaragua 2
NO - Norvegia 2
SI - Slovenia 2
SN - Senegal 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AD - Andorra 1
AM - Armenia 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
DZ - Algeria 1
ET - Etiopia 1
GA - Gabon 1
GD - Grenada 1
GH - Ghana 1
GM - Gambi 1
HN - Honduras 1
HU - Ungheria 1
JM - Giamaica 1
LA - Repubblica Popolare Democratica del Laos 1
MG - Madagascar 1
MK - Macedonia 1
MN - Mongolia 1
NG - Nigeria 1
NP - Nepal 1
OM - Oman 1
PH - Filippine 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
SC - Seychelles 1
Totale 12.127
Città #
Southend 1.045
Moscow 575
Singapore 523
Jacksonville 510
Chandler 454
Dallas 416
Woodbridge 387
Ashburn 365
Ann Arbor 247
Hong Kong 229
Dublin 182
Verona 180
Munich 167
Beijing 152
Houston 113
New York 100
Los Angeles 93
Helsinki 89
Jinan 81
Nanjing 80
Wilmington 79
Lawrence 74
Princeton 74
Shenyang 73
The Dalles 68
Turku 48
Hebei 46
Tianjin 46
Ho Chi Minh City 44
Buffalo 42
Haikou 41
Zhengzhou 39
Hanoi 37
Columbus 36
Nanchang 32
Santa Clara 30
São Paulo 28
Changsha 27
Dong Ket 27
Brussels 26
Hangzhou 26
Sindelfingen 26
Boardman 24
Ningbo 24
Redmond 23
Taiyuan 22
Jakarta 21
Redwood City 21
Milan 20
Taizhou 20
Warsaw 20
Guangzhou 19
San Jose 19
Chicago 17
Council Bluffs 17
Denver 17
Seoul 17
Tokyo 17
London 16
Seattle 16
Stockholm 16
Johannesburg 15
Amsterdam 14
Brooklyn 14
Düsseldorf 14
Nürnberg 13
Atlanta 12
Belo Horizonte 12
Cambridge 12
Jiaxing 12
Lancaster 12
Falls Church 11
Frankfurt am Main 11
Lanzhou 11
Montreal 11
San Francisco 11
Ankara 10
Chennai 10
Fairfield 10
Fuzhou 10
Redondo Beach 10
Curitiba 9
Norwalk 9
Toronto 9
Boston 8
Dearborn 8
Kent 8
Mumbai 8
Nuremberg 8
Orem 8
Phoenix 8
Poplar 8
Querétaro 8
Auburn Hills 7
Falkenstein 7
Manchester 7
Philadelphia 7
Vienna 7
Jyväskylä 6
Madrid 6
Totale 7.704
Nome #
Interferon-alpha-engineered Multipotent Mesenchymal Stromal Cells for the treatment of myeloma 289
IFN-gamma- Mediated Upmodulation of MHC Class I Expression Activates Tumor-Specific Immune Response in a Mouse Model of Prostate Cancer 278
Immune checkpoint blockade therapy mitigates systemic inflammation and affects cellular FLIP-expressing monocytic myeloid-derived suppressor cells in non-progressor non-small cell lung cancer patients 274
IFNalpha-producing bone marrow mesenchymal stem cells (BM-MSCs) contrast tumor growth in a mouse myeloma model. 261
Identification of microRNAs implicated in the late differentiation stages of normal B cells suggests a central role for miRNA targets ZEB1 and TP53 260
IFN-gamma- Mediated Upmodulation of MHC Class I Expression Associated to a B7-1-Expressing Tumor Cell Vaccine Activates Tumor-Specific Immune Response in a Mouse Model of Prostate Cancer. 253
Cell contact-dependent PMN HLA-DR and CD69 membrane expression induced by autologous mono-lymphocytes and cell lines. 241
Autologous cellular vaccine overcomes cancer immunoediting in a mouse model of myeloma 227
Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3 224
A novel cell line and xenograft model of ampulla of Vater adenocarcinoma 213
Homing and Efficacy Assessment of interferon-alpha-engineered mesenchymal stromal cells in a mouse plasmocytoma model 204
Efficacy assessment of interferon-alpha-engineered mesenchymal stromal cells in a mouse plasmacytoma model 199
Effective control of acute myeloid leukaemia and acute lymphoblastic leukaemia progression by telomerase specific adoptive T-cell therapy 199
CXCL12-MEDIATED NF-KAPPAB AND C-JUN ACTIVATION REGULATES INTERLEUKIN 8 PRODUCTION IN HUMAN T-LYMPHOBLASTIC LEUKEMIA 198
Induction of human immunodeficiency virus neutralizing antibodies using fusion complexes 196
Feasibility of telomerase-specific adoptive T-cell therapy for B-cell chronic lymphocytic leukemia and solid malignancies 195
Analysis of CIITA encoding AIR-1 gene promoters in insulin-dependent diabetes mellitus and rheumatoid arthritis patients from the northeast of Italy: absence of sequence variability 194
Induction and expansion of an anti-tumor immune response by B7-1+ tumor cells in dependence on the anatomical site of delivery and the dose applied 193
A family of trans-acting factors with distinct regulatory functions control expression of MHC class II genes. 190
Autologous cellular vaccine allows control of cancer immunoediting in a mouse model of plasmacytoma. 189
Benign acute viral myositis in African migrants: a clinical, serological and pathological study. 188
IFN-gamma-mediated upmodulation of MHC class I expression activates tumor-specific immune response in a mouse model of prostate cancer 186
Hyperthermic treatment at 56 °C induces tumour-specific immune protection in a mouse model of prostate cancer in both prophylactic and therapeutic immunization regimens 183
A non-parametric method for the analysis of experimental tumour growth data 173
The puzzling uniqueness of the heterotrimeric G15 protein and its potential beyond hematopoiesis 170
Bone marrow-, spleen- and thymus-derived mesenchymal stem cells favour the growth of myeloma cells in a mouse model 169
Interferon-alpha-engineered Multipotent Mesenchymal Stromal Cells for the treatment of myeloma 169
Induction of an antitumour adaptive immune response elicited by tumour cells expressing de novo B7-1 mainly depends on the anatomical site of their delivery: the dose applied regulates the expansion of the response 168
Induction of immunosuppressive functions and NF-κB by FLIP in monocytes 166
Alternative splicing of HLA-DQB transcripts and secretion of HLA-DQ beta-chain proteins: allelic polymorphism in splicing and polyadenylylation sites 164
Effects of dietary wheat germ deprivation on the immune system in wistars rats: a pilot study 160
Cell lineage-specific and developmental stage-specific controls of MHC class-II-antigen expression. 159
Interrupting the nitrosative stress fuels tumor-specific cytotoxic T lymphocytes in pancreatic cancer 155
The Emerging Immunological Role of Post-Translational Modifications by Reactive Nitrogen Species in Cancer Microenvironment 154
A rapid and improved method for generating cDNA libraries in plasmid and phage vectors 153
Immune regulation by Mesenchymal Stem Cells derived from adult spleen and thymus. 151
Constitutive and inducible expression of HLA class II genes in normal cells is under the control of the AIR-1-encoded CIITa trans-activator 150
Active suppression of the class II transactivator-encoding AIR-1 locus is responsible for the lack of Major Histocompatibility Complex class II gene expression observed during differentiation from B cells to plasma cells. 146
HLA class II expression in uninducible hepatocarcinoma cells after transfection of AIR-1 gene product CIITA. Acquisition of antigen processing and presentation capacity. 146
CONSTITUTIVE AND INDUCIBLE EXPRESSION OF HLA CLASS II GENES IN NORMAL CELLS UNDER THE CONTROL OF THE AIR-1-ENCODED CIITA TRANS-ACTIVATOR 145
The Endless Saga of Monocyte Diversity 145
Distinct regulation of HLA class II and class I cell surface expression in the THP-1 macrophage cell line after bacterial phagocytosis 144
Identification of Ricin A chain HLA II-restricted epitopes by human T-cell clones. 144
Evidence for a trans-acting activator function regulating the expression of the human CD5 antigen. 143
Expression of myelin basic protein (MBP) epitopes in human non-neural cells revealed by two anti-MBP IgM monoclonal antibodies 138
Inducible and constitutive MHC class II gene expression. Distinct tissue-specific genetic controls. 137
Expression of MHC class I and class II antigens in pancreatic adenocarcinomas. 135
Mitochondrial DNA polymorphism analyzed by restriction endonucleases in two sardinian populations 131
Structure and regulation of MHC system 130
The Engagement Between MDSCs and Metastases: Partners in Crime 130
Functional significance of polymorphism among MHC class II gene promoters. 127
Interfacing polymeric scaffolds with primary pancreatic ductal adenocarcinoma cells to develop 3D cancer models. 127
A rapid and improved method for generating cDNA libraries in plasmid and phage lambda vectors 126
Divergent evolution in the mechanisms controlling MHC class II gene transcription in mouse and human. 125
SEQUENCE POLYMORPHISM OF HLA-DP b CHAINS 124
Expression of HLA antigens in human pancreatic carcinomas 122
Myelin basic protein epitopes secreted by human T cells encounter natural autoantibodies in the serum 121
Identification of ricin A-chain HLA class II-restricted epitopes by human T-cell clones 120
Evidence for a specific post-transcriptional mechanisms controlling the expression of HLA-DQ, but not -DR and -DP, molecules. 119
Local ablation disrupts immune evasion in pancreatic cancer 115
Organization, polymorphism and regulation of class II genes of the major histocompatibility complex. 114
Interaction of human pancreatic ductal adenocarcinoma cells with polymeric scaffolds to develop tissue-engineered cancer models. 113
Regulation of CD5 gene expression in interspecies human x mouse T cell hybrids 110
Staphylococcal enterotoxin-dependent lysis of MHC class II negative target cells by cytolytic T lymphocytes 109
Transcriptional regulation of MHC class II genes 108
Forecasting the growth of multicell tumour spheroids: implications for the dynamic growth of solid tumours. 108
HLA-DBQ1 typing of north east italian IDDM patients using amplified DNA oligonucleotide probes and a rapid DNA-enzyme immunoassay(DEIA). 107
Oscillating growth patterns of multicellular tumour spheroids 106
Polimorfismo genetico mitocondriale in popolazioni sarde esposte a differente pressione selettiva malarica 104
"Open Sesame" to the complexity of pattern recognition receptors of myeloid-derived suppressor cells in cancer 99
MHC class II gene regulation: some historical considerations on a still ontogenetic and phylogenetic puzzle 98
MHC: AN INTEGRATED GENETIC SYSTEM WHICH ORCHESTRATES THE IMMUNE RESPONSE. 97
Mitochondrial DNA polymorphism in four Sardinian villages 94
HLA-DQB1 typing of north east Italian IDDM patients using amplified DNA, oligonucleotide probes and a rapid DNA-enzyme immunoassay (DEIA) 93
A Complex Metabolic Network Confers Immunosuppressive Functions to Myeloid-Derived Suppressor Cells (MDSCs) within the Tumour Microenvironment 86
Study of the optimal conditions for obtaining fusion complexes to be used as broad spectrum anti HIV-1 vaccine 86
Evidence for a specific post-transcriptional mechanism controlling the expression of HLA-DQ, but not -DR and -DP, molecules 85
Moonlighting Proteins Are Important Players in Cancer Immunology 84
MHC: orchestrating the immune response 65
Exploring the HLA complex in autoimmunity: from the risk haplotypes to the modulation of expression 54
null 33
Totale 12.288
Categoria #
all - tutte 38.532
article - articoli 29.580
book - libri 0
conference - conferenze 7.751
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.201
Totale 77.064


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021407 0 0 0 0 0 100 13 57 47 12 120 58
2021/2022709 73 223 6 34 26 18 30 41 37 28 60 133
2022/20231.320 89 154 135 237 122 282 11 82 150 7 26 25
2023/2024644 14 42 47 102 63 110 30 48 2 40 96 50
2024/20252.045 92 113 76 273 103 85 164 133 329 106 183 388
2025/20263.851 377 353 399 975 1.415 332 0 0 0 0 0 0
Totale 12.288